Interlace Medical
Founded Year
2005Stage
Acquired | AcquiredTotal Raised
$26.25MValuation
$0000Loading...
Loading...
Interlace Medical Patents
Interlace Medical has filed 1 patent.
Application Date | Grant Date | Title | Related Topics | Status |
|---|---|---|---|---|
9/7/2007 | 7/27/2010 | Robotics, Robots, Healthcare occupations, Medical ethics, Medical terminology | Grant |
Application Date | 9/7/2007 |
|---|---|
Grant Date | 7/27/2010 |
Title | |
Related Topics | Robotics, Robots, Healthcare occupations, Medical ethics, Medical terminology |
Status | Grant |
Latest Interlace Medical News
Feb 7, 2014
February 7, 2014 by Brad Perriello The U.S. Patent & Trademark Office nixes 2 patents at issue in Smith & Nephew's long-running infringement battle with Interlace Medical and subsequent acquirer Hologic. The U.S. Patent & Trademark Office dealt a setback to Smith & Nephew (FTSE: SN , NYSE: SNN ) last month when it invalidated claims in a pair of patents at the core of a long-running infringement dispute with Interlace Medical and its subsequent acquirer, Hologic (NSDQ: HOLX ). Smith & Nephew sued Interlace in 2010, alleging infringement of a pair of patents with the MyoSure fibroid tumor device, and filed against Hologic after the Interlace buyout in January 2011. Sign up to get our free newsletters delivered right to your inbox. In September 2012, a jury awarded $4 million in damages to cover Smith & Nephew's lost profits from the infringement. Further damages, however, can't yet be decided because the jury's verdict was too vague, according to Judge Rya Zobel of the U.S. District Court for Massachusetts. In October 2013, Hologic asked a federal judge in Massachusetts to revisit that loss . Last June, Judge Rya Zobel of the U.S. District Court for Massachusetts upheld that decision but found that any damages owed by Hologic to the British medical products giant couldn't yet be determined.
Interlace Medical Frequently Asked Questions (FAQ)
When was Interlace Medical founded?
Interlace Medical was founded in 2005.
Where is Interlace Medical's headquarters?
Interlace Medical's headquarters is located at 139 Newbury Street, Framingham.
What is Interlace Medical's latest funding round?
Interlace Medical's latest funding round is Acquired.
How much did Interlace Medical raise?
Interlace Medical raised a total of $26.25M.
Who are the investors of Interlace Medical?
Investors of Interlace Medical include Hologic, New Leaf Venture Partners, Spray Venture Partners, HLM Venture Partners, Tekla Capital Management and 5 more.
Who are Interlace Medical's competitors?
Competitors of Interlace Medical include NuVasive, Gynesonics, Endologix, FloShield, Cabochon Aesthetics and 7 more.
Loading...
Compare Interlace Medical to Competitors
Uromedica develops minimally invasive medical devices that treat unmet medical needs in the area of urinary incontinence and related disorders. Products (sold under the ACT and ProACT brands) are based on adjustable balloon technology. Conditions being treated are post-prostatectomy incontinence in men and stress incontinence in women (after earlier interventions have failed).
Gynesonics women's healthcare company focused on minimally invasive solutions for symptomatic uterine fibroids. It develops the sonata system for the transcervical treatment of symptomatic uterine fibroids under intrauterine sonography guidance. The sonata system uses radiofrequency energy to ablate fibroids under intrauterine sonography guidance. Gynesonics was founded in 2005 and is based in Redwood City, California.
Ouroboros Medical is a medical devices for minimally invasive spinal fusion
Varix Medical Corporation, located in Sunnyvale, Calif., is a medical device company focused on developing products for the minimally invasive treatment of chronic venous insufficiency, commonly referred to as "varicose veins." For patients with advanced stages of varicose veins, laser- and RF-based (radiofrequency) treatments have been developed, but each device has deficiencies making them less-than-optimal solutions. Varix Medical's platform technology will enable physicians to efficiently and effectively treat more types of diseased veins than is currently possible when using either laser or RF devices. Additional treatable vessels include tortuous sub-truncal vessels and other visible smaller varicose veins. The Varix platform employs a vapor-based endovenous ablation system that will consist of a disposable catheter, a catheter introducer or delivery system, and a reusable vapor generator. RCT and Coronis Medical Ventures LLC., formed Varix in August 2007 and acquired the technology under license from Tsunami MedTech LLC. Coronis and RCT have been the primary in investors in Varix.
InnerPulse develops minimally invasive devices for cardiac rhythm management
NICO Corporation is a company focused on revolutionizing minimally invasive neurosurgery in the healthcare industry. The company offers patented technologies that integrate imaging and intervention, providing a safe and minimally disruptive approach to brain surgery. NICO primarily serves the healthcare sector, particularly in the field of neurosurgery. It was founded in 2007 and is based in Indianapolis, Indiana.
Loading...